Hemophilia A, Congenital Clinical Trial
Official title:
A Multinational Phase IV Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis
The primary objective of this study is to investigate weekly prophylaxis dosing regimens used in standard clinical practice. In addition the study will capture reported bleed rate, pattern of change in KOVALTRY prophylaxis dose & dosing frequency, reason for choice of treatment regimen, FVIII product switch pattern, patient treatment satisfaction and adherence, KOVALTRY pharmacokinetic data (if performed), KOVALTRY consumption, as well as safety data.
Open label, prospective, non-interventional, single arm study in patients receiving KOVALTRY as prophylaxis therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03095287 -
Alphanate in Immune Tolerance Induction Therapy
|
Phase 2 | |
| Completed |
NCT03034044 -
Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
|
||
| Completed |
NCT02253693 -
Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of Accelerometry
|
N/A | |
| Completed |
NCT02796222 -
Factor Product Utilization and Health Outcomes in Patients With Hemophilia
|